Thomas Van Blarcom

Emulsion Based Selection of T7 Promoters of Varying Activity

Andrew D. Ellington, Matthew Levy, Eric A. Davidson, 2010, Pacific Symposium on Biocomputing.

Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli

George Georgiou, Robert Mabry, Thomas Van Blarcom, 2007, Nature Biotechnology.

Preclinical Evaluation of a Potent Anti-Bcma CD3 Bispecific Molecule for the Treatment of Multiple Myeloma

Amy Y. Chen, Thomas Van Blarcom, S. Panowski, 2016 .

ALLO-715, an Allogeneic BCMA CAR T Therapy Possessing an Off-Switch for the Treatment of Multiple Myeloma

Thomas Van Blarcom, R. Galetto, J. Chaparro-Riggers, 2018, Blood.